Small-molecule inhibitors targeting ICAM3 signaling molecules, such as Src and PI3K, could markedly inhibit ICAM3 expression, inflammation, and cancer stem cell stemness, suggesting a close relationship between ICAM3 and cancer stem cells (Figure 2D) 42. This evidence concerns the gene SRC and cancer.